Innovate Biopharmaceuticals Inc Analyst Event to Discuss NASH Data and Provide Clinical Updates Transcript
Greetings and welcome to Innovate analyst event conference call. I would now like to turn the conference over to your host, Jen Zimmons. Thank you. You may begin.
Good afternoon, ladies and gentlemen, and welcome to the Innovate Biopharmaceuticals DDW 2019 Analyst Event. As a reminder, this call is being recorded and webcasted. Joining our call are Dr. Stephen Harris (sic) [Harrison], a leading clinical investigator in NASH; Dr. Laumas, our Chairman and CEO; and Dr. Griffin, our Chief Medical Officer.
Before we begin, I'd like to remind everyone that this conference call includes forward-looking statements. Each forward-looking statement contained in this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information regarding these factors are described in the risk factors and management's discussion and analysis section of our most recent quarterly and annual financial reports. The forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
